Please ensure Javascript is enabled for purposes of website accessibility

Why Akorn, Inc. Is Soaring 39% Today

By Todd Campbell - Mar 22, 2016 at 1:32PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Solid preliminary results and the potential to wrap up a review of its past financials are sparking a rally.

Image source: Akorn, Inc.

What: Following the release of its preliminary fourth-quarter and full-year financials, shares in Akorn (NASDAQ: AKRX) are rallying 39.05% at 1:00 p.m. Tuesday. 

So what: The mid-sized generic pharmaceutical company reports that preliminary full-year sales clocked in at $985 million, and that those sales translated into adjusted EPS of $1.93.

Sales were supported by 15 FDA product approvals that resulted in 12 new product launches targeting markets with combined revenue of $577 million.

The company also provided guidance for 2016 that includes a sales target of between $1.06 and $1.08 billion and adjusted EPS within a range of $2.10 to $2.20.

Further, the company updated investors on its progress in getting up-to-date on its audited financials with the SEC. The company says it's completed a review of its 2014 financials and that it estimates it overstated revenue that year by $35 million. Akorn's management believes it's on track to file its 2014 and 2015 financials with the SEC by May 9, 2016.

Now what: The company's shares have been weighed down by worry over what would be discovered by auditors, and given that the amount estimated to be restated hasn't changed since the last management update, and filings are on schedule to be brought current in the next few months, a major overhang could soon be removed.

If so, then investors may be right to be cheering Akorn's results. After all, even after today's rally, the company's shares are still trading at only 13.3 times this year's profit outlook. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Akorn, Inc. Stock Quote
Akorn, Inc.
AKRX

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
338%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.